Herbal Supplements Make Inroads in Europe Diet Pills Market with Total Sales Projected to surpass US$ 611.6 Mn by 2031: Fact MR

A Fact.MR survey on Europe diet pills market offers detailed analysis on the key growth drivers and restraints affecting demand.

170 Pages Market Research Survey by Fact MR, A Market Research and Competitive Intelligence, Offers Incisive Coverage on Global Europe Diet Pills Market Growth

A Fact.MR survey on Europe diet pills market offers detailed analysis on the key growth drivers and restraints affecting demand. The survey also provides insights into competitive trends prevailing in Europe, identifying key market players and analyzing the impact of their growth strategies

Fact.MR – A Market Research and Competitive Intelligence Provider: The diet pills demand in Europe will consistently rise at 2.6% CAGR between 2021 and 2031. As per Fact MR, overall sales in Europe will total US$ 669 Mn in 2021. Historically, sales of diet pills in Europe have been observed at 0.7% CAGR between 2016 and 2020.

Glucomannan diet pills demand is anticipated to grow from US$ 258.1 Mn in 2020 to around US$ 361.2 Mn by 2031, while sales of herbal supplements is expected to reach US$ 611.6 Mn in 2031 from a valuation of US$ 455.1 Mn in 2020.

Nowadays, an increasing number of people are focusing on including dietary supplements such as diet pills in their routine. This trend is making inroads in countries such as the U.K. and Germany on account of the prevalence of obesity and consequent focus on adopting a healthier lifestyle.

According to World Health Organization (WHO), in 2017 around 29% of geriatric population were categorized as obese in the U.K. Against this backdrop, focus on a healthy living is on the rise. Consequently the demand for fat blocker pills and demand for weight loss pills have gained tremendous traction in the country.

As per Fact MR, sales of diet suppressants are expected to rise at 3% CAGR in Germany. Increasing focus on health and wellness will remain the primary growth drivers. Thanks to rising awareness, self-medication has become immensely popular in Germany, consequently creating opportunities for sales of diet pills.

Strategic partnerships remain highly sought-after among companies aiming at competitive advantage. As the focus on capacity expansion continues rising, an increasing number of market players will invest in merger and acquisitions, “said a Fact MR analyst.

Request a report sample to gain comprehensive insights at


Key Takeaways for Europe Diet Pills Market Research Report:

  • Demand for prescription-based pills for weight loss will continue rising in the U.K. Fact MR predicts overall diet pill sales in the country to surpass US$ 193 Mn by 2031.
  • Sales of diet pills in Germany will rise at 3% CAGR owing to rising concerns about health and wellness.
  • By drug class, glucomannan segment accounted for over 39.5% of the Europe market in 2020.
  • By drug type, herbal diet supplements sales totalled US$ 444.3 Mn in 2020 owing to increase in demand for organic product consumption.

Growth Drivers:

  • Rising spending on dietary supplements and nutrition are driving demand for diet pills for appetite control.
  • Expansion of distribution channels for diet pills will bolster sales opportunities in Europe.
  • Rising adoption of drugs for weight loss and obesity-control will accelerate demand for weight loss pills in Europe.
  • Increasing availability across e-commerce platforms will encourage diet pill sales in Europe.

Key Restraints:

  • High cost of drug development is hindering demand for diet pills.
  • Stringent regulations imposed by research and development of obesity related drugs will restrain market growth.
  • Adoption of off-label drugs limits penetration of actual drugs which is restraining market growth.

Get Customized Report on Europe Diet Pills Market


Competitive Landscape:

Key players are focusing on expansion in emerging countries and introducing features in their product lines. For instance,

  • In September 2019, Currax™ Pharmaceuticals LLC declared acquisition of Nalpropion Pharmaceuticals, Inc. Currax has global rights to CONTRAVE, which is a leading prescription of weight loss brand medication.
  • In June 2020, Holland, Barrett, and Deliveroo are partnering to deliver more than 200 products from 50 stores across the U.K.
  • In September 2018, Nature’s Way Products, LLC and Natural Products Canada introduced an investment agreement for investing in new companies which works in natural products sectors such as supplements and dietary ingredients.

Key players are operating in the market include

  • GlaxoSmithKline plc.
  • Cheplapharm Arzneimittel GmbH
  • Holland & Barrett Retail Limited
  • Cresent Pharma.
  • Himalaya Wellness (The Himalaya Drug Company)
  • Nature’s Way Products, LLC
  • zeinpharma
  • SimplySupplements
  • Lindens Health + Nutrition

More Insights on the Global Europe Diet Pills Sales Outlook

Fact MR provides an unbiased analysis of the Europe diet pills demand outlook, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the Europe diet pills market with a detailed segmentation on the basis of:

Drug Class

  • Lipase Inhibitors
  • Choline
  • Glucomannan
  • Garcinia Cambogia
  • Others

Drug Type

  • Prescription Drugs
  • OTC Drugs
  • Herbal Supplements


  • Metabolism Raising Diet Pills
  • Fat Blocking Diet Pills
  • Appetite Controlling Diet Pills
  • Others

Distribution Channel

  • Diet Pills Sold at Hospital Pharmacies
  • Diet Pills Sold at Retail Pharmacies
  • Diet Pills Sold at Clinics
  • Online Sales of Diet Pills (e-Commerce)
    • Stores
    • Amazon
    • Pharmacies
  • Sales of Diet Pills by Drug Stores

Key Questions Covered in the Diet supplements Sales Outlook Report

  • The report offers insight into Europe diet pills demand outlook for 2021-2031
  • The market study also highlights projected sales growth for diet pills in Europe between 2021 and 2031
  • Europe diet pills demand survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Europe diet pills market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Explore Fact.MR’s Coverage on the Healthcare Domain

Herbal Drugs Market - Herbal medicines have few negative effects, hence the severe side effects of allopathic treatments are driving up demand for herbal medicines. The market for herbal pharmaceuticals would rise due to the high acceptance of Ayurveda in Asia-Pacific nations like India and China. Additionally, the growing number of retail pharmacies dedicated to the selling and promotion of herbal goods would increase the herbal pharmaceuticals market’s revenue development.

OTC Analgesics Market - With the great availability of medications for alleviating various forms of pain in distribution stores, OTC analgesic pharmaceuticals are generally purchased in huge amounts. The growth of the worldwide OTC analgesics market is projected to be influenced by these factors. The availability of over-the-counter analgesics has made managing pain sensations simple and practical, and these are now prescribed alongside licensed medications as maintenance therapy.

Parenteral Drug Market - The increasing product pipeline and high number of FDA product approvals are expected to boost revenue shares in the monoclonal antibodies product type sector. As seen in the graph below, the segment of big molecules parenteral pharmaceuticals will exhibit an increasing year-on-year growth trajectory, with growth levelling off after the mid-term forecast. Companies in the parenteral medicines market are concentrating on regional expansion and locating new facilities near target customers.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR